Special aspects of insulin therapy in pregnancies complicated by gestational diabetes mellitus (GDM);Besonderheiten der insulintherapie bei gestationsdiabetes (GDM)

Geburtshilfe und Frauenheilkunde

Volumn 60, Issue 7, 2000, Pages 366-379

  Weiss, P A M ^a   Walcher, W ^a   Scholz, H S ^a  

^a Geburtshilflich Gynakologische Universitats Klinik   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; HUMAN INSULIN;

ARTICLE; DRUG INDICATION; FETUS; GLUCOSE BLOOD LEVEL; HUMAN; HYPERGLYCEMIA; HYPERINSULINISM; INSULIN RELEASE; INSULIN RESISTANCE; INSULIN TREATMENT; POSTPRANDIAL STATE; PREGNANCY COMPLICATION; PREGNANCY DIABETES MELLITUS;

EID: 0033940972     PISSN: 00165751     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2000-7386     Document Type: Article

References (124)

1. Bashiri H. Prophylactic insulin treatment of gestational diabetes (glucose intolerance in pregnancy). University of Teheran, Iran. Abstractband, Second International Graz Symposium on Gestational Diabetes. Puch, Austria, Medizinisch-wissenschaftliche Abteilung. Milupa Informations-Service 1992; 51
2. Bellmann O. Therapy of gestational diabetes. Acta Endocrinol 1986; 227: 50-55
3. Bergman M, Seaton TB, Auerhahn CC et al. The incidence of gestational hypoglycemia in insulin-dependent and non-insulin-dependent diabetic women. New York State J Med 1986; 86: 174-177
4. Berne C, Wibell L, Lindmark G. Ten year experience of insulin treatment in gestational diabetes. Acta Paediatr Scand 1985; 74 (Suppl 320): 85-93
5. Buchanan TA, Kjos SL, Montoro MN, Wu PYK, Madrilejo NG, Gonzalez M, Nunez V, Pantoja PM, Xiang A. Use of fetal ultrasound to select metabolic therapy for pregnancies complicated by mild gestational diabetes. Diabetes Care 1994; 17: 275-283
6. Buchanan TA, Metzger BE, Freinkel N, Bergman RN. Insulin sensitivity and B-cell responsiveness to glucose during late pregnancy in lean and moderately obese women with normal glucose tolerance or mild gestational diabetes. Am J Obstet Gynecol 1990; 162: 1008-1014
7. Buchanan TA, Unterman TG, Metzger BE. The medical management of diabetes in pregnancy. Clin Perinatol 1985; 12: 625-650
8. Burkart W, Dame WR, Ruppin E, Schneider HPG. Die Bedeutung von Hormonen im Fruchtwasser. I. Insulin und C-Peptid. Geburtsh u Frauenheilk 1985; 44: 781-786
9. Burke BJ, Sheriff RJ, Savage PE, Dixon HG. Diabetic twin pregnancy: An unequal result. Lancet 1979; 1: 1372-1373
10. Carpenter MW, Canick JA, Star J, Carr SR, Burke ME, Shahinian K. Fetal hyperinsulinism at 14-20 weeks and subsequent gestational diabetes. Obstet Gynecol 1996; 87: 89-93
11. Casper DJ, Benjamin F. Immunoreactive insulin in amniotic fluid. Obstet Gynecol 1970; 35: 389-393
12. Cheney C, Shragg P, Hollingsworth D. Demonstration of heterogeneity in gestational diabetes by a 400 Kcal breakfast meal tolerance test. Obstet Gynecol 1985; 65: 17-23
13. Chertow BS, Baranetsky NG, Sivitz WI et al. The effects of human Insulin on antibody formation in pregnant diabetics and their newborns. Obstet Gynecol 1988; 72: 724-728
14. Coetzee E, Jackson WPU. Diabetes newly diagnosed during pregnancy. S Afr Med J 1979; 56: 467-475
15. Combs CA, Gunderson E, Kitzmiller JL, Gavin LA, Main EK. Relationship of fetal macrosomia to maternal postprandial glucose control during pregnancy. Diabetes Care 1992; 15: 1271-1277
16. Coustan DR. The use of prophylactic insulin in women with gestational diabetes. In: Weiss PAM, Coustan DR (eds). Gestational Diabetes. Wien, New York: Springer; 1988: 134-141
17. Coustan DR, Imarah J. Prophylactic insulin treatment of gestational diabetes reduces the incidence of macrosomia, operative delivery, and birth trauma. Am J Obstet Gynecol 1984; 150: 836-842
18. Coustan DR, Lewis SB. Insulin therapy for gestational diabetes. Obstet Gynecol 1978; 51: 306-310
19. Crandall BF, Howard J, Lebherz TB, Rubinstein L, Sample WF, Sati D. Follow-up of 2000 second-trimester amniocentesis. Obstet Gynecol 1980; 56: 625-628
20. Crombach G, Linnenkamp J, Müller C, Wolff F. Insulin- und C-Peptidkonzentrationen im Fruchtwasser bei normalen und diabetischen Schwangeren. Arch Gynecol Obstet 1989; 245: 284-285
21. Damm P, Kühl C, Hornnes P, Mølsted-Pedersen L. A longitudinal study of plasma insulin and glucagon in women with previous gestational diabetes. Diabetes Care 1995; 18: 654-665
22. Dandona P, Besterman HS, Freedman DB, Boag F, Taylor AM, Beckett AG. Macrosomia despite well-controlled diabetic pregnancy. Lancet 1984; I: 737
23. De Veciana M, Major CA, Morgan MA, Asrat T, Toohey JS, Lien JM, Evans AT. Postprandial versus preprandial blood glucose monitoring in women with gestational diabetes mellitus requiring insulin therapy. N Engl J Med 1995; 333: 1237-1241
24. Dempe A, Michaelis D, Heinke P, Franke D, Seitz W, Barthel D, Bauch K. Häufigkeit des Gestationsdiabetes sowie der Veränderung der Insulinsekretion bei Schwangeren. 1. Mitteilung: Untersuchungen von diabetesverdächtigen Schwangeren mittels des Glukoseinfusionstests (GIT). Zbl Gynäkol 1978; 100: 1559-1565
25. DePrins F, VanAssche A, Milner RDG. C-peptide levels in amniotic fluid in experimental fetal growth retardation. Biol Neonate 1983; 43: 181
26. Diamond MP, Salyer SL, Vaughn WK, Cotton R, Boehm FH. Reassessment of White's classification and Pedersen's prognostically bad signs of diabetic pregnancies in insulin-dependent pregnancies. Am J Obstet Gynecol 1987; 156: 599-604
27. Dooley SL, Metzger BE, Cho N. Gestational diabetes: influence of race on disease prevalence and perinatal outcome in an U. S. population. Diabetes 1991; 40 (Suppl 2): 25-29
28. Draisey TF, Gagneja GL, Thibert RJ. Pulmonary surfactant and amniotic fluid insulin. Obstet Gynecol 1977; 50: 197-199
29. Drexel H, Bichler A, Sailer S, Breier C, Lisch H, Braunsteiner H, Patsch JR. Prevention of perinatal morbidity by tight metabolic control in gestational diabetes mellitus. Diabetes Care 1988; 11: 761-768
30. Fadel HE, Saad SA, Davis H, Nelson GH. Fetal lung maturity in diabetic pregnancies: Relation among amniotic fluid insulin, prolactin, and lecithin. Am J Obstet Gynecol 1988; 159: 457-463
31. Fallucca F, Gargiulo P, Troili F et al. Amniotic fluid insulin, C-peptide concentrations, and fetal morbidity in infants of diabetic mothers. Am J Obstet Gynecol 1985; 153: 534-540
32. Fraser R. Diabetic control in pregnancy and intrauterine growth of the fetus. Br J Obstet Gynaecol 1995; 102: 275-277
33. Fuhrmann K, Semmler K, Reiher H. Das Verhalten des HPL (Humanes plazentares Laktogen) unter Glukoseinfusionsbehandlung in der Spätschwangerschaft. Zbl Gynäkol 1980; 102: 1031-1034
34. Gabbe SG, Mestman JH, Freeman RK, Anderson GV, Lowensohn RI. Management and outcome of class A diabetes mellitus. Am J Obstet Gynecol 1977; 127: 465-469
35. Gestation and Diabetes in France Study Group: Multicenter survey of diabetic pregnancy in France. Diabetes Care 1991; 14: 994-1000
36. Goldberg JD, Franklin B, Lasser D, Jonsay DL, Hausknecht RU, Ginsberg-Fellner F, Berkowitz RL. Gestational diabetes: Impact of home glucose monitoring on neonatal birth weight. Am J Obstet Gynecol 1986; 154: 546-550
37. Goldman M, Kitzmiller J, Abrams B, Cowan R, Laros R. Obstetric complications with GDM. Effects of maternal weight. Diabetes 1991; 40 (Suppl 2): 79-82
38. Greco AV, Rebuzzi AG, Bellati U et al. Fetal origin of amniotic fluid insulin in the human mother. Clin Endocrinol (Oxf) 1980; 12: 67-70
39. Haeusler MCH, Konstantiniuk P, Dorfer M, Weiss PAM. Amniotic fluid insulin testing in gestational diabetes: Safety and acceptance of amniocentesis. Am J Obstet Gynecol 1998; 179: 917-920
40. Hall R, Rhodes P, Newman R. Glucose disappearance in infants of diabetic mothers. Relationship to lowest neonatal blood glucose and amniotic fluid insulin. Early Hum Dev 1978; 1: 257-264
41. Hare JW. Levels of glycemia as management goals. Diabetes 1991; 40 (Suppl 2): 193
42. Harris MI, Robbins DC. Prevalence of adult-onset IDDM in the U. S. population. Diabetes Care 1994; 17: 1337-1340
43. Heise T, Weyer C, Serwas A, Heinrichs S, Osinga J, Roach P, Woodworth J, Gudat U, Heinemann L. Time-action profiles of novel premixed preparations of insulin Lispro and NPL insulin. Diabetes Care 1998; 21: 800-803
44. Hofmann HMH, Weiss PAM, Kainer F. Insulin treatment of gestational diabetes. The basal bolus concept. In: Weiss PAM, Coustan DR (eds). Gestational Diabetes. Wien, New York: Springer 1988: 142-152
45. Hofmann HMH, Weiss PAM, Pürstner P, Haas J, Gmoser G, Tamussino K, Schmon B. Serum fructosamine and amniotic fluid insulin levels in patients with gestational diabetes and healthy control subjects. Am J Obstet Gynecol 1990; 162: 1175-1177
46. Hohenauer L. Intrauterine Wachstumskurven für den Deutschen Sprachraum. Z Geburtsh u Perinat 1980; 184: 167-179
47. Hollingsworth DR. Alterations of maternal metabolism in normal and diabetic pregnancies: Differences in insulin-dependent and gestational diabetes. Am J Obstet Gynecol 1983; 146: 417-429
48. Homko CJ, Sivan E, Nyirjesy P, Reece EA. The interrelationship between ethnicity and gestational diabetes in fetal macrosomia. Diabetes Care 1995; 18: 1442-1445
49. Hommel G, Muck BR. Ein diskriminanzanalytischer Ansatz zur Beurteilung der Glukosetoleranz Schwangerer anhand von Seruminsulin-Verlaufsbeobachtungen. Arch Gynecol Obstet 1977; 223: 315-321
50. Hopp H, Glöckner E, Vollert W, Ruhnke M. Indications for and results of insulin therapy for gestational diabetes. Freie Universität Berlin und Institut für Diabetesforschung Karlsberg, BRD. Abstractband, Second International Graz Symposium on Gestational Diabetes. Milupa Information-Service 1992: 51
51. Hopp H, Vollert W, Ragosch V et al. Indication and results of insulin therapy for gestational diabetes mellitus. J Perinat Med 1996; 24: 521-530
52. Huddleston JF, Cramer MK, Vroon DH. A rationale for omitting two-hour postprandial glucose determinations in gestational diabetes. Am J Obstet Gynecol 1993; 169: 257-264
53. Jacobson J, Cousins L. A population-based study of maternal and perinatal outcome in patients with gestational diabetes. Am J Obstet Gynecol 1989; 161: 981-986
54. Johnstone FD, Nasrat AA, Prescott RJ. The effect of established and gestational diabetes on pregnancy outcome. Br J Obstet Gynaecol 1990; 97: 1009-1015
55. Jovanovic L, Ilic SS, Gutierrez M, Bastyri EJ. Insulin Lispro (LP) improves postprandial glucose (PPG) without increased immunogenicity or hypoglycemia in gestational diabetic women (GDM). Diabetes 1998; 47 (Suppl 1): A49
56. Jovanovic-Peterson L, Peterson CM, Reed GF, Metzger BE, Mills JL, Knopp RH, Aarons JH. Maternal postprandial glucose levels and infant birth weight: The diabetes in early pregnancy study. The national institute of child health and human development-diabetes in early pregnancy study. Am J Obstet Gynecol 1991; 164: 103-111
57. Kitzmiller JL. Sweet success with diabetes: The development of insulin therapy and glycemic control for pregnany. Diabetes Care 1993; 16 (Suppl 3): 107-121
58. Krew MA, Kehl RJ, Thomas A, Catalano PM. Relation of amniotic fluid C-peptide levels to neonatal body composition. Obstet Gynecol 1994; 84: 96-100
59. Kühl C, Hornnes PJ, Anderson O. Etiology and pathophysiology of gestational diabetes mellitus. Diabetes 1985; 34 (Suppl 2): 66-70
60. Laakso M, Pyorala K. Age of onset and type of diabetes. Diabetes Care 1985; 8: 114-117
61. Landon MB, Gabbe SG, Sachs L. Management of diabetes mellitus and pregnancy: A survey of obstetricians and maternal-fetal specialists. Obstet Gynecol 1990; 75: 635-640
62. Landon MB, Sonek J, Foy P, Hamilton L, Gabbe S. Sonographic measurement of fetal humeral soft tissue thikness in pregnancy complicated by GDM. Diabetes 1991; 40 (Suppl 2): 66-70
63. Langer O. Scientific rationale for management of diabetes in pregnancy. Recent approaches with innovative computer-based technology. Diabetes Care 1988; 11 (Suppl 1): 67-72
64. Langer O, Anyaegbunam A, Brustman L, Guidetti D, Mazze RS. Gestational diabetes: Insulin requirements in pregnancy. Am J Obstet Gynecol 1987; 157: 669-675
65. Langer O, Berkus M, Brustman L, Anyaegbunam A, Mazze R. Rationale for insulin management in gestational diabetes mellitus. Diabetes 1991; 40 (Suppl 2): 186-190
66. Langer O, Levy J, Brustman L, Anyaegbunam A, Merkatz R, Divon M. Glycemic control in gestational diabetes mellitus - how tight is tight enough: small for gestational age versus large for gestational age? Am J Obstet Gynecol 1989; 161: 646-653
67. Langer O, Lozlowski S, Brustman L. Abnormal growth patterns in diabetes in pregnancy: a longitudinal study. Isr J med Sci 1991; 27: 516-523
68. Langer O, Mazze R. The relationship between large for gestational age infants and glycemic control in women with gestational diabetes. Am J Obstet Gynecol 1988; 159: 1478-1483
69. Langer O, Rodriguez DA, Xenakis EMJ, McFarland MB, Berkus MD, Arredondo F. Intensified versus conventional management of gestational diabetes. Am J Obstet Gynecol 1994; 170: 1036-1047
70. Leikin E, Jenkins JH, Graves WL. Prophylactic insulin in gestational diabetes. Obstet Gynecol 1987; 70: 587-592
71. Libman I, Songer T, LaPorte R. How many people in the U. S. have IDDM? Diabetes Care 1993; 16: 841-842
72. Lin CC, Moawad AH, River P, Blix P, Abraham M, Rubenstein AH. Amniotic fluid C-peptide as an index for intrauterine fetal growth. Am J Obstet Gynecol 1981; 139: 390-396
73. Lin CC, River Ph, Moawad AH, Lowensohn RJ, Blix PM, Abraham M, Rubenstein AH. Prenatal assessment of fetal outcome by amniotic fluid C-peptide levels in pregnant diabetic women. Am J Obstet Gynecol 1981; 141: 671-676
74. Lurie S, Matzke A, Weissman A, Gotlibe Z, Friedman A. Outcome of pregnancy in class A1 and A2 gestational diabetic patients delivered beyond 40 weeks' gestation. Am J Perinatol 1992; 9: 484-488
75. Maresh M, Gillmer MDG, Beard RW, Alderson CS, Bloxham BA, Elkeles RS. The effect of diet and insulin on metabolic profiles of women with gestational diabetes mellitus. Diabetes 1985; 34 (Suppl 2): 88-93
76. McManus RM, Ryan EA. Insulin requirements in insulin-dependent and insulin-requiring GDM women during final month of pregnancy. Diabetes Care 1992; 15: 1325-1327
77. Melton LJ, Palumbo PJ, Chu CP. Incidence of diabetes mellitus by clinical type. Diabetes Care 1983; 6: 75-81
78. Metzger BE, Silverman BL, Freinkel N, Dooley SL, Ogata ES, Green OC. Amniotic fluid insulin as a predictor of obesity. Arch Dis Child 1990; 65 (Suppl 10) 1050-1052
79. Moles KW, McMullen JK. Insulin resistance and hypomagnesaemia: case report. Br Med J 1982; 285: 262
80. Molsted-Pedersen L, Damm P, Buschard K. Diabetes Diagnosed During Pregnancy: Follow-up Studies. In: Sutherland HW, Stowers JM, Pearson DWM (eds). Carbohydrate Metabolism in Pregnancy and the Newborn. London, Berlin, Heidelberg, New York, Paris, Tokyo: Springer, 1989: 277-286
81. Muck BR, Hommel G. Plasma insulin response following intravenous glucose in gestational diabetes. Arch Gynecol Obstet 1977; 223: 259-268
82. Newman RL, Tutera G. The glucose-insulin ratio in amniotic fluid. Obstet Gynecol 1976; 47: 599-601
83. Nolan CJ, Proietto J. The feto-placental glucose steal phenomenon is a major cause of maternal metabolic adaptation during late pregnancy. Diabetologia 1994; 37: 976-984
84. Ogata ES, Freinkel N, Metzger BE et al. Perinatal islet function in gestational diabetes: assessment by cord plasma C-peptide and amniotic fluid insulin. Diabetes Care 1980; 3: 425-429
85. Persson B, Heding LG, Lunell NO, Pschera H, Stangenberg M, Wagner J. Fetal beta cell function in diabetic pregnancy. Amniotic fluid concentrations of proinsulin, insulin, and C-peptide during the last trimester of pregnancy. Am J Obstet Gynecol 1982; 144: 455-459
86. Persson B, Lunell NO. Metabolic control in diabetic pregnancy. Variations in plasma concentrations of glucose, free fatty acids, glycerol, ketone bodies, insulin and human chorionic somatomammotropin during the last trimester. Am J Obstet Gynecol 1975; 122: 737-745
87. Persson B, Stangenberg M, Hansson U, Nordlander E. Gestational diabetes mellitus. Comparative evaluation of two treatment regimens, diet versus insulin and diet. Diabetes 1985; 34 (Suppl 2): 101-105
88. Philipson E, Kalhan S, Rosen M, Edelberg S, Williams T, Riha M. Gestational diabetes mellitus. Is further improvement necessary? Diabetes 1985; 34 (Suppl 2): 55-60
89. Position Statement. Gestational Diabetes. Diabetes Care 1991; 14 (Suppl 2): 5-6
90. Rayburn W. Changes in insulin therapy during pregnancy. Am J Perinatol 1985; 2: 271-275
91. Rizzo T, Metzger BE, Burns WJ, Burns K. Correlations between antepartum maternal metabolism and intelligence of offspring. N Engl J Med 1991; 325: 911-916
92. Roversi GD, Cannusio V, Gargiulo M, Candiani CB. The intensive care of perinatal risk in pregnant diabetics (136 cases): A new therapeutic scheme for the best control of maternal disease. J Perinat Med 1973; 1: 114-119
93. Roversi GD, Gargiulo M, Nicolini U, Ferrazzi E, Pedretti E, Gruft L, Tronconi G. Maximal tolerated insulin therapy in gestational diabetes. Diabetes Care 1980; 3: 489-494
94. Roversi GD, Gargiulo M, Nicolini U, Pedretti E, Marini A, Barbarani V, Peneff P. A new approach to the treatment of diabetic pregnant women. Report of 479 cases seen from 1963 to 1975. Am J Obstet Gynecol 1979; 135: 567-576
95. Ruggiero L, Spirito A, Bond A, Coustan D, McGarvey S. Impact of social support and stress on compliance in women with gestational diabetes. Diabetes Care 1990; 13: 441-443
96. Russell G, Farmer G, Lloyd DJ, Pearson DWM, Ross IS, Stowers JM, Sutherland HW, Visser GHA, van Ballegooie E, Sluiter WJ, Verhaaren HA, Craen M, De Gomme P, Rubens R, Parewijck W, Derom R. Macrosomy despite well-controlled diabetic pregnancy. Lancet 1984; I: 283-285
97. Santiago JV, Clarke WL, Arias F. Studies with a pancreatic beta cell simulator in the third trimester of pregnancies complicated by diabetes. Am J Obstet Gynecol 1978; 132: 455-463
98. Schäfer U, Dupak J, Heinze T, Dudenhausen JW, Vetter K. Glukosetoleranz in der Schwangerschaft und Fruchtwasserinsulin bei der Geburt. Geburtsh u Frauenheilk 1996; 56: 414-417
99. Semmler K, Semmler S, Steindel E, Lambeck M, Minkwitz H-G. Die Früherfassung des Gestationsdiabetes - ein Faktor zur Senkung der perinatalen Mortalität und Morbidität. Zentralbl Gynäkol 1990; 112: 697-705
100. Silverman BL, Cho NH, Richards GE, Metzger BE. Fetal hyperinsulinism in offspring of diabetic mothers: a strong predictor of impaired glucose tolerance (IGT) in adolescence (Abstract). Pediatr Res 1993; 33: 196A
101. Silverman BL, Metzger BE, Cho NH, Leob CA. Impaired glucose tolerance in adolescent offspring of diabetic mothers. Diabetes Care 1995; 18: 611-617
102. Spellacy WN, Buhi WC, Birk SA. Carbohydrate metabolism in women with a twin pregnancy. Obstet Gynecol 1980; 55: 688-691
103. Spellacy WN, Buhi WC, Bradley B, Holsinger KK. Maternal, fetal and amniotic fluid levels of glucose, insulin and growth hormone. Obstet Gynecol 1973; 41: 323-331
104. Stangenberg M, Persson B, Vaclavinkova V. Amniotic fluid volumes and concentrations of C-peptide in diabetic pregnancies. Br J Obstet Gynaecol 1982; 89: 536-542
105. Tchobroutsky G, Heard I, Tchobroutsky C, Eschwege E. Amniotic fluid C-peptide in normal and insulin-dependent diabetic pregnancies. Diabetologia 1980; 18: 289
106. Teller WM, Cornblath M, Engelhardt W, Gutberlet RL, Heisig N, Meny R, Mintz DH, Mueller-Heubach E, Riegel K. Probleme des Diabetes mellitus in der Schwangerschaft und während der Neugeborenenperiode: Ein internationales schriftliches Rundtischgespräch. Pädiatr Prax 1976; 17: 439-459
107. Thompson DJ, Porter KB, Gunnells DJ, Wagner PC, Spinnato JA. Prophylactic insulin in the management of gestational diabetes. Obstet Gynecol 1990; 75: 960-964
108. Thompson DM, Dansereau J, Creed M, Ridell L. Tight glucose control results in normal perinatal outcome in 150 patients with gestational diabetes. Obstet Gynecol 1994; 83: 362-366
109. Thorsson AV, Hintz RL. Insulin receptors in the newborn. Increase in receptor affinity and number. N Engl J Med 1977; 297: 908-912
110. Turner RC, Harris E, Bloom SR, Uren C. Relation of fasting plasma glucose concentration to plasma insulin and glucagon concentrations. Studies in latent diabetics and women who have produced large-for-dates babies. Diabetes 1977; 26: 166-171
111. Wechter DJ, Kaufmann RC, Amankwah KS, Rightmire DA, Eardley SP, Verhulst S, Zinzilieta M, Young J, Teich J, Singleton JA et al. Prevention of neonatal makrosomia in gestational diabetes by the use of intensive dietary therapy and home glucose monitoring. Am J Perinatol 1991; 8: 131-134
112. Weerasiri T, Riley SF, Sheedy MT, Walstab JE, Wein P. Amniotic fluid insulin values in women with gestational diabetes as a predictor of emerging diabetes mellitus. Aust N Z J Obstet Gynaecol 1993; 33: 358-361
113. Weiss PAM. Diabetes in pregnancy: Lessons from the fetus. In: Dornhorst A, Hadden DR (eds). Diabetes and Pregnancy: An International Approach to Diagnosis and Management. Chichester, New York, Brisbane, Toronto, Singapore: John Wiley & Sons Ltd 1996: 221-240
114. Weiss PAM. Klinische Bedeutung des Geburtsgewichts bei Diabetes mellitus. Gynäkologe 1998; 31: 58-67
115. Weiss PAM, Hofmann H. Intensified conventional insulin therapy for the pregnant diabetic patient. Obstet Gynecol 1984; 64: 629-637
116. Weiss PAM, Hofmann H. Monitoring pregnancy in diabetes: Amniotic fluid. Diabetes Nutr Metab 1990; 3 (Suppl 2): 31-35
117. Weiss PAM, Hofmann H, Winter R, Pürstner P. Gestational diabetes and screening during pregnancy. Obstet Gynecol 1984; 63: 776-780
118. Weiss PAM, Hofmann HMH. Indikation zur Insulintherapie bei Gestationsdiabetes. In: Weiss, PAM (ed). Kohlenhydratstoffwechselstörungen und Schwangerschaft. Wien, München, Bern: Wilhelm Maudrich 1987: 95-99
119. Weiss PAM, Hofmann HMH, Kainer F, Haas JG. Fetal outcome in gestational diabetes with elevated amniotic fluid insulin levels. Dietary versus insulin treatment. Diabetes Res Clin Pract 1988; 5: 1-7
120. Weiss PAM, Kainer F, Haeusler M, Pürstner P, Haas J. Amniotic fluid insulin levels in nondiabetic pregnant women: an update. Arch Gynecol Obstet 1998; 262: 81-86
121. Weiss PAM, Walcher W, Scholz HS. Der vernachlässigte Gestationsdiabetes: Risiken und Folgen. Geburtsh u Frauenheilk 1999; 59: 535-544
122. Weiss PAM. Gestational diabetes: A survey and the Graz approach to diagnosis and therapy. In Weiss PAM, Coustan DR (eds). Gestational Diabetes. Wien, New York: Springer; 1988: 1-55
123. Widness JA, Cowett RM, Coustan DR, Carpenter MW, Oh W. Neonatal morbidities in infants of mothers with glucose intolerance in pregnancy. Diabetes 1985; 34 (Suppl 2): 61-65
124. Zoupas C, Mastrantonakis E, Diakakis I et al. The importance of insulin administration in gestational diabetes. Acta Endocrinol 1984; 265: 26-28